A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Registration Number
- NCT01013922
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to explore if certain characteristics, easily detected within a regular primary care setting, may indicate that a patient at risk for COPD (45 ≤ age ≤ 80 years and a smoking history of ≥ 15 pack years) is prone to have a diagnosis of COPD according to Medical Products Agency guidelines.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 309
Inclusion Criteria
- Patients with a history of smoking one pack of cigarettes per day for 15 years or more
Exclusion Criteria
- Known Chronic Obstructive Pulmonary Disease
- Known severe cardiovascular disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The patients will test their lung function with a COPD-6 screener for COPD and compare with regular spirometry. Medical records will be checked for health care contacts with respiratory diagnosis during the last 24 months prior to the study visit. There will only be one visit in the study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇸🇪Varnamo, Sweden